NASDAQ · APRE

Aprea Therapeutics, Inc.

Closing price · Nov 13, 2026 $0.4162
Last insider buy price $0.89 Paid by SrVP/CFO/Prin Fin & Acct Ofcr John Hamill on Jan 30, 2026 (Form 4). Not today's price.

Latest quarter · ended Sep 30, 2026

Cash got weaker

descriptionFiled Nov 4, 2026
Cash from operationsWorse
−$3.73M
Quarter ended Dec 31, 2024: −$3.51M cash from operationsQuarter ended Mar 31, 2025: −$3.63M cash from operationsQuarter ended Jun 30, 2025: −$3.13M cash from operationsQuarter ended Sep 30, 2025: −$3.17M cash from operationsQuarter ended Dec 31, 2025: −$2.96M cash from operationsQuarter ended Mar 31, 2026: −$2.76M cash from operationsQuarter ended Jun 30, 2026: −$3.28M cash from operationsQuarter ended Sep 30, 2026: −$3.73M cash from operations
Dec '24Sep '26
vs. −$3.17M a year ago
Share countDiluting
+124.9%
Quarter ended Dec 31, 2024: 5.49M sharesQuarter ended Mar 31, 2025: 5.53M sharesQuarter ended Jun 30, 2025: 5.83M sharesQuarter ended Sep 30, 2025: 6.31M sharesQuarter ended Dec 31, 2025: 11.45M sharesQuarter ended Mar 31, 2026: 12.38M sharesQuarter ended Jun 30, 2026: 12.59M sharesQuarter ended Sep 30, 2026: 14.19M shares
Dec '24Sep '26
14.19M shares vs. 6.31M a year ago

Numbers come from the company's own 10-Q and 10-K reports filed with the SEC. Each bar is one quarter, oldest on the left. The colored bar is the latest. Hover over or tap a bar to see its number.

Smart money pulse

What insiders and funds are doing

Mixed Insiders: as of Nov 13 Funds: as of Jun 30, 2026
−1000+100 0
  • info
    No real insider sales in 12 months. Planned 10b5-1 sales and tax withholding are left out.

−100 means everyone selling, +100 everyone buying. This is data, not advice.

How the Pulse works

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.

Who owns it

29 funds report owning APRE, up from 22

Holdings as of Jun 30, 2026
New9
Added5
Held10
Trimmed5
Sold out2

Insider trades · last 12 months

Real buys and sales

● Open-market buy● Open-market sale
CEOCFOOther officersDirectorsDecJanFebMarAprMayJunJulAugSepOctNovStock grant · Mar 12 · 20,175 shStock grant · Mar 12 · 10,095 shStock grant · Jun 16 · 25,080 sh · 8 peopleOpen-market buy · Dec 10 · $25.1KOpen-market buy · Dec 10 · $5.85KOpen-market buy · Jan 30 · $25KOpen-market buy · Jan 30 · $5.07K
CEOCFOOther officersDirectorsDecFebAprJunAugOctStock grant · Mar 12 · 20,175 shStock grant · Mar 12 · 10,095 shStock grant · Jun 16 · 25,080 sh · 8 peopleOpen-market buy · Dec 10 · $25.1KOpen-market buy · Dec 10 · $5.85KOpen-market buy · Jan 30 · $25KOpen-market buy · Jan 30 · $5.07K

Last 12 months. No real trades in the last 6.

Showing 4 real trades. Hidden: 10 stock grants. Those happen on a schedule and say little about what an insider thinks. Bigger dot means a bigger trade.

Real trades, newest first

Jan 30 Oren Gilad Past buys: 0 of 4 beat President/CEO, Director Open-market buy $25K 28,100 sh at $0.89
Jan 30 John Hamill Past buys: 0 of 4 beat SrVP/CFO/Prin Fin & Acct Ofcr Open-market buy $5.07K 5,700 sh at $0.89
Dec 10 Marc Duey Director Open-market buy $25.1K 21,459 sh at $1.17
Dec 10 John Hamill Past buys: 0 of 4 beat SrVP/CFO/Prin Fin & Acct Ofcr Open-market buy $5.85K 5,000 sh at $1.17

"Past buys: 2 of 3 beat" means this insider bought stock in 3 earlier quarters, and in 2 of them what they bought did better than the typical stock over the next 6 months. A past record is data, not a forecast.

Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.

Top holders

Biggest funds in APRE

As of Jun 30, 2026

"Owns" is shares reported divided by shares outstanding.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast